Katherine Rohde ([email protected])

National Security Controls and the Life Sciences Sector: BIOSECURE Act, Section 1260H, and COINS Act Developments

Following the U.S. Department of Defense’s addition of WuXi AppTec and other biotech companies to its list of Chinese military companies, these entities may soon face restrictions under the BIOSECURE Act, while lawmakers are also pushing to subject biotechnology investments and licensing deals with Chinese firms to outbound investment controls under the COIN